Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma
The study has demonstrated a safe combination of stereotactic radiation therapy and immune checkpoint inhibitor immunotherapy in patients with metastatic uveal melanoma. The combination shows a potential treatment option for this patient cohort since no other effective therapies are available at present.
Authors
- Lev Demidov (ORCID: https://orcid.org/0000-0002-8562-6082)
- Kristina V. Orlova (ORCID: https://orcid.org/0000-0002-0442-5917)
- V.V. Nazarova (ORCID: https://orcid.org/0000-0003-0532-6061)
- А.А. Yarovoy (ORCID: https://orcid.org/0000-0003-2219-7054)
- V.А. Yarovaya (ORCID: https://orcid.org/0000-0001-8937-7450)
- О. П. Трофимова (ORCID: https://orcid.org/0000-0002-7204-370X)
- И. Ж. Шубина (ORCID: https://orcid.org/0000-0002-9374-3158)
- Д. С. Романов (ORCID: https://orcid.org/0000-0003-3942-4102)
- Z.R. Magomedova (ORCID: https://orcid.org/0009-0006-9145-0905)
- Raman Maskalenka
Institutions
- Pirogov Russian National Research Medical University (RU)
- Steris (United States) (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fonc.2025.1567504
- Citations
- 4
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.83